- Home
- FTFT vs ONVO Comparison
FTFT vs ONVO Comparison
Compare FTFT & ONVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTFT
- ONVO
- Stock Information
- Founded
- FTFT N/A
- ONVO 2007
- Country
- FTFT United States
- ONVO United States
- Employees
- FTFT N/A
- ONVO N/A
- Industry
- FTFT Business Services
- ONVO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FTFT Consumer Discretionary
- ONVO Health Care
- Exchange
- FTFT Nasdaq
- ONVO Nasdaq
- Market Cap
- FTFT 6.2M
- ONVO 5.7M
- IPO Year
- FTFT N/A
- ONVO N/A
- Fundamental
- Price
- FTFT $0.19
- ONVO $0.40
- Analyst Decision
- FTFT
- ONVO
- Analyst Count
- FTFT 0
- ONVO 0
- Target Price
- FTFT N/A
- ONVO N/A
- AVG Volume (30 Days)
- FTFT 11.9M
- ONVO 22.4M
- Earning Date
- FTFT 04-15-2025
- ONVO 02-19-2025
- Dividend Yield
- FTFT N/A
- ONVO N/A
- EPS Growth
- FTFT N/A
- ONVO N/A
- EPS
- FTFT N/A
- ONVO N/A
- Revenue
- FTFT $18,543,659.00
- ONVO $122,000.00
- Revenue This Year
- FTFT N/A
- ONVO $59.08
- Revenue Next Year
- FTFT N/A
- ONVO $18.24
- P/E Ratio
- FTFT N/A
- ONVO N/A
- Revenue Growth
- FTFT N/A
- ONVO N/A
- 52 Week Low
- FTFT $0.18
- ONVO $0.32
- 52 Week High
- FTFT $1.21
- ONVO $1.83
- Technical
- Relative Strength Index (RSI)
- FTFT 34.34
- ONVO 45.32
- Support Level
- FTFT $0.20
- ONVO $0.39
- Resistance Level
- FTFT $0.25
- ONVO $0.46
- Average True Range (ATR)
- FTFT 0.04
- ONVO 0.20
- MACD
- FTFT -0.00
- ONVO -0.03
- Stochastic Oscillator
- FTFT 1.23
- ONVO 3.53
About FTFT Future FinTech Group Inc.
Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and cryptocurrency mining farm in the U.S. The company's reportable segments include the Supply chain financing/trading segment which generates key revenue, and the Asset management service segment.
About ONVO Organovo Holdings Inc.
Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.